{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:37:10Z","timestamp":1792291030295,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.tice.2025.102909","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T10:20:03Z","timestamp":1744885203000},"page":"102909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Advances in Cell-based therapies for peripheral arterial disease"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-5299","authenticated-orcid":false,"given":"Maisa","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2025.102909_bib1","unstructured":"Adminisration U.S FAD. Focus Area: Regenerative Medicine. [Updated 2022 Sep 09]. In: FDA Gov [Internet]. Available from: \u3008https:\/\/www.fda.gov\/science-research\/focus-areas-regulatory-science-report\/focus-area-regenerative-medicine\u3009. Accessed 2024 October 31 2024."},{"issue":"3","key":"10.1016\/j.tice.2025.102909_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIR.0000000000001153","article-title":"Health disparities in peripheral artery disease: a scientific statement from the American heart association","volume":"148","author":"Allison","year":"2023","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.tice.2025.102909_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.34172\/apb.2023.025","article-title":"Current and novel emerging medical therapies for peripheral artery disease: a literature review","volume":"13","author":"Arabzadeh","year":"2023","journal-title":"Adv. Pharm. Bull."},{"issue":"23","key":"10.1016\/j.tice.2025.102909_bib4","doi-asserted-by":"crossref","first-page":"16752","DOI":"10.3390\/ijms242316752","article-title":"Adipose-derived stem cells to treat ischemic diseases: the case of peripheral artery disease","volume":"24","author":"Arderiu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.tice.2025.102909_bib5","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3109\/14653249.2011.605620","article-title":"Autologous bone marrow mononucleated cell preparation for the clinical treatment of acute myocardial infarction and peripheral arterial disease","volume":"13","author":"Astori","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.tice.2025.102909_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101138","article-title":"The evolving regulatory landscape in regenerative medicine","volume":"91","author":"Beetler","year":"2023","journal-title":"Mol. Asp. Med"},{"issue":"4","key":"10.1016\/j.tice.2025.102909_bib7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5966\/sctm.2015-0227","article-title":"Concise review: endothelial progenitor cells in regenerative medicine: applications and challenges","volume":"5","author":"Chong","year":"2016","journal-title":"Stem Cells Transl. Med."},{"issue":"20","key":"10.1016\/j.tice.2025.102909_bib8","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.2024.6834","article-title":"Urgent need for regulatory oversight of human cells, tissues, and cellular and tissue-based products","volume":"331","author":"Dickson","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.tice.2025.102909_bib9","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s41598-018-19581-x","article-title":"The microRNA regulatory landscape of MSC-derived exosomes: a systems view","volume":"8","author":"Ferguson","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.tice.2025.102909_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrcardio.2016.179","article-title":"Peripheral artery disease: epidemiology and global perspectives","volume":"14","author":"Fowkes","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"9901","key":"10.1016\/j.tice.2025.102909_bib11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.tice.2025.102909_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.coph.2018.01.005","article-title":"Cell therapy for peripheral artery disease","volume":"39","author":"Frangogiannis","year":"2018","journal-title":"Curr. Opin. Pharm."},{"issue":"8","key":"10.1016\/j.tice.2025.102909_bib13","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1042\/CS20200023","article-title":"From animal models to patients: the role of placental microRNAs, miR-210, miR-126, and miR-148a\/152 in preeclampsia","volume":"134","author":"Frazier","year":"2020","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.tice.2025.102909_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13287-019-1185-1","article-title":"The potential and limitations of induced pluripotent stem cells to achieve wound healing","volume":"10","author":"Gorecka","year":"2019","journal-title":"Stem Cell Res. Ther."},{"issue":"Pt B","key":"10.1016\/j.tice.2025.102909_bib15","article-title":"Hypoxic preconditioning-engineered bone marrow mesenchymal stem cell-derived exosomes promote muscle satellite cell activation and skeletal muscle regeneration via the miR-210-3p\/KLF7 mechanism","volume":"142","author":"Guo","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.tice.2025.102909_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","article-title":"The secretion profile of mesenchymal stem cells and potential applications in treating human diseases","volume":"7","author":"Han","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.tice.2025.102909_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010413","article-title":"Bone marrow-derived vasculogenic mesenchymal stem cells enhance in vitro angiogenic sprouting of human umbilical vein endothelial cells","volume":"24","author":"Jang","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.tice.2025.102909_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1054576","article-title":"Endothelial cell dysfunction: implications for the pathogenesis of peripheral artery disease","volume":"9","author":"Kavurma","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.tice.2025.102909_bib19","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1038\/s41598-020-60352-4","article-title":"Development of a two-stage limb ischemia model to better simulate human peripheral artery disease","volume":"10","author":"Krishna","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.tice.2025.102909_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.62347\/MZKI8393","article-title":"Fetal progenitor cells for treatment of chronic limb ischemia","volume":"13","author":"Kukharchuk","year":"2024","journal-title":"Am. J. Stem Cells"},{"issue":"2","key":"10.1016\/j.tice.2025.102909_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jtcvs.2011.08.053","article-title":"Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product","volume":"144","author":"Lasala","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.tice.2025.102909_bib22","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.tice.2025.102909_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/nu14153086","article-title":"Advanced glycation end products and their effect on vascular complications in type 2 diabetes mellitus","volume":"14","author":"Lee","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.tice.2025.102909_bib24","first-page":"404","article-title":"US state laws on medical freedom and investigational stem cell procedures: a call to focus on state-based legislation","volume":"26","author":"Matthews","year":"2024"},{"issue":"12","key":"10.1016\/j.tice.2025.102909_bib25","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.1161\/CIR.0000000000000708","article-title":"Perfusion assessment in critical limb ischemia: principles for understanding and the development of evidence and evaluation of devices: a scientific statement from the American heart association","volume":"140","author":"Misra","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.tice.2025.102909_bib26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/00914037.2023.2215376","article-title":"Application of stem cells, growth factors, small molecules, and biological macromolecules on nerve regeneration: a review and future direction","volume":"73","author":"Nemati Mahand","year":"2024","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"issue":"6","key":"10.1016\/j.tice.2025.102909_bib27","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/mt.2012.52","article-title":"Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled restore-cli trial","volume":"20","author":"Powell","year":"2012","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.tice.2025.102909_bib28","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1161\/CIRCRESAHA.113.300565","article-title":"Cell therapy of peripheral arterial disease: from experimental findings to clinical trials","volume":"112","author":"Raval","year":"2013","journal-title":"Circ. Res"},{"issue":"7","key":"10.1016\/j.tice.2025.102909_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073601","article-title":"The role of circulating biomarkers in peripheral arterial disease","volume":"22","author":"Saenz-Pipaon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tice.2025.102909_bib30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s13287-022-03148-9","article-title":"Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia","volume":"13","author":"Shirbaghaee","year":"2022","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.tice.2025.102909_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13287-023-03390-9","article-title":"Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI)","volume":"14","author":"Shirbaghaee","year":"2023","journal-title":"Stem Cell Res. Ther."},{"issue":"9","key":"10.1016\/j.tice.2025.102909_bib32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","article-title":"Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential","volume":"41","author":"Song","year":"2020","journal-title":"Trends Pharm. Sci."},{"issue":"2","key":"10.1016\/j.tice.2025.102909_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0043-57257","article-title":"Medical management of peripheral artery disease","volume":"40","author":"Sullivan","year":"2023","journal-title":"Semin Interv. Radio."},{"issue":"5","key":"10.1016\/j.tice.2025.102909_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-0038-1676453","article-title":"Clinical assessment of peripheral arterial disease in the office: what do the guidelines say?","volume":"35","author":"Tummala","year":"2018","journal-title":"Semin Interv. Radio."},{"issue":"A (A)","key":"10.1016\/j.tice.2025.102909_bib35","doi-asserted-by":"crossref","first-page":"A39","DOI":"10.1016\/j.jvs.2007.02.068","article-title":"Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing","volume":"45","author":"Velazquez","year":"2007","journal-title":"J. Vasc. Surg."},{"issue":"18","key":"10.1016\/j.tice.2025.102909_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12186081","article-title":"Limb salvage and survival in chronic limb-threatening ischemia: the need for a fast-track team-based approach","volume":"12","author":"Ventoruzzo","year":"2023","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.tice.2025.102909_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4252\/wjsc.v16.i2.191","article-title":"Extracellular vesicles derived from mesenchymal stem cells mediate extracellular matrix remodeling in osteoarthritis through the transport of microRNA-29a","volume":"16","author":"Yang","year":"2024","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.tice.2025.102909_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8179075","article-title":"Mesenchymal stem cell therapy for ischemic tissues","volume":"2018","author":"Yong","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.tice.2025.102909_bib39","unstructured":"Zemaitis M.R., Boll J.M., Dreyer M.A. Peripheral Arterial Disease. [Updated 2023 May 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430745\/\u3009. Accessed 2024 October 24 2024."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816625001892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816625001892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T15:28:28Z","timestamp":1750260508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816625001892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":39,"alternative-id":["S0040816625001892"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2025.102909","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Cell-based therapies for peripheral arterial disease","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2025.102909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102909"}}